Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. Read this story
Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot. Read this story
More from Yahoo Finance | Sanofi Bloomberg Novavax Inc licensing agreement Vaccine Novavax Inc NASDAQ:NVAX